Logo image of MEGI

NYLI CBRE GBL INFR MGA TRM F (MEGI) Stock Price, Quote, News and Overview

NYSE:MEGI - New York Stock Exchange, Inc. - US56064Q1076 - Currency: USD

14.35  +0.08 (+0.56%)

Fundamental Rating

2

Overall MEGI gets a fundamental rating of 2 out of 10. We evaluated MEGI against 0 industry peers in the Unkown industry. MEGI may be in some trouble as it scores bad on both profitability and health. MEGI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MEGI had positive earnings in the past year.
MEGI had a positive operating cash flow in the past year.
MEGI Yearly Net Income VS EBIT VS OCF VS FCFMEGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 9.62%
ROE 13.15%
ROIC 5.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MEGI Yearly ROA, ROE, ROICMEGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

Industry RankSector Rank
OM 72.28%
PM (TTM) 100%
GM 73.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEGI Yearly Profit, Operating, Gross MarginsMEGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 100 -100

2

2. Health

2.1 Basic Checks

MEGI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MEGI Yearly Shares OutstandingMEGI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M 40M 50M
MEGI Yearly Total Debt VS Total AssetsMEGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that MEGI is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of MEGI is 2.45, which is a good value as it means it would take MEGI, 2.45 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.36 indicates that MEGI is not too dependend on debt financing.
Although MEGI does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.45
Altman-Z 1.23
ROIC/WACCN/A
WACCN/A
MEGI Yearly LT Debt VS Equity VS FCFMEGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

A Current Ratio of 0.03 indicates that MEGI may have some problems paying its short term obligations.
MEGI has a Quick Ratio of 0.03. This is a bad value and indicates that MEGI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
MEGI Yearly Current Assets VS Current LiabilitesMEGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100M 200M 300M 400M

2

3. Growth

3.1 Past

MEGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 264.41%, which is quite impressive.
The Revenue has grown by 16.82% in the past year. This is quite good.
EPS 1Y (TTM)264.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.45%
Revenue 1Y (TTM)16.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%75.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEGI Yearly Revenue VS EstimatesMEGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M 80M

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.40 indicates a rather cheap valuation of MEGI.
When comparing the Price/Earnings ratio of MEGI to the average of the S&P500 Index (27.35), we can say MEGI is valued rather cheaply.
Industry RankSector Rank
PE 7.4
Fwd PE N/A
MEGI Price Earnings VS Forward Price EarningsMEGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.61
EV/EBITDA N/A
MEGI Per share dataMEGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

MEGI has a Yearly Dividend Yield of 10.71%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.36, MEGI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.71%

5.2 History

MEGI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
MEGI Yearly Dividends per shareMEGI Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

77.23% of the earnings are spent on dividend by MEGI. This is not a sustainable payout ratio.
DP77.23%
EPS Next 2YN/A
EPS Next 3YN/A
MEGI Yearly Income VS Free CF VS DividendMEGI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 -500M -1B
MEGI Dividend Payout.MEGI Dividend Payout, showing the Payout Ratio.MEGI Dividend Payout.PayoutRetained Earnings

NYLI CBRE GBL INFR MGA TRM F

NYSE:MEGI (7/25/2025, 1:06:08 PM)

14.35

+0.08 (+0.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners50.62%
Inst Owner Change0.55%
Ins Owners0.08%
Ins Owner Change1.67%
Market Cap746.92M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 10.71%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP77.23%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-25 2025-08-25 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.4
Fwd PE N/A
P/S 7.4
P/FCF 6.61
P/OCF 6.61
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)1.94
EY13.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.17
FCFY15.13%
OCF(TTM)2.17
OCFY15.13%
SpS1.94
BVpS14.76
TBVpS14.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.62%
ROE 13.15%
ROCE 9.51%
ROIC 5.52%
ROICexc 5.52%
ROICexgc 5.52%
OM 72.28%
PM (TTM) 100%
GM 73.27%
FCFM 111.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.45
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 111.88%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.23
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)264.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%75.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.82%
OCF growth 3YN/A
OCF growth 5YN/A